Coagulation disorders in dogs with hepatic disease

Veterinary Journal

Volumn 185, Issue 2, 2010, Pages 163-168

  Prins, M ^a   Schellens, C J M M ^a   van Leeuwen, M W ^a   Rothuizen, J ^a   Teske, E ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Coagulation disorders; DIC; Dog; Liver disease

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR; D DIMER; PROTEIN C;

ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TIME; CHRONIC HEPATITIS; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; DOG DISEASE; FEMALE; HEMOSTASIS; HISTOPATHOLOGY; LIVER CIRRHOSIS; LIVER DISEASE; MALE; NONHUMAN; OUTCOME ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; PROTEIN FUNCTION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; ANIMAL; BLOOD; DOG; METABOLISM; PROSPECTIVE STUDY; PROTHROMBIN TIME; VETERINARY;

CANIS FAMILIARIS;

ANIMALS; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; DOG DISEASES; DOGS; FEMALE; HEMOSTASIS; LIVER DISEASES; MALE; PARTIAL THROMBOPLASTIN TIME; PLATELET COUNT; PROSPECTIVE STUDIES; PROTHROMBIN TIME;

EID: 77954158676     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2009.05.009     Document Type: Article

References (48)

1. Badylak S.F. Coagulation disorders and liver disease. The veterinary clinics of North America. Small Animal Practice 1988, 18:87-93.
2. Badylak S.F., Dodds W.J., Van Vleet J.F. Plasma coagulation factor abnormalities in dogs with naturally occurring hepatic disease. American Journal of Veterinary Research 1983, 44:2336-2340.
3. Bateman S.W., Mathews K.A., Abrams-Ogg A.C.G., Lumsden J.H., Johnstone I.B. Evaluation of the effect of storage at -70 degreesC for six months on hemostatic function testing in dogs. Canadian Journal of Veterinary Research 1999, 63:216-220.
4. Bateman S.W., Mathews K.A., Abrams-Ogg A.C., Lumsden J.H., Johnstone I.B., Hillers T.K., Foster R.A. Diagnosis of disseminated intravascular coagulation in dogs admitted to an intensive care unit. Journal of the American Veterinary Medical Association 1999, 215:798-804.
5. Ben-Ari Z., Osman E., Hutton R.A., Burroughs A.K. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?. American Journal of Gastroenterology 1999, 94:2977-2982.
6. Burns E.R., Goldberg S.N., Wenz B. Paradoxic effect of multiple mild coagulation factor deficiencies on the prothrombin time and activated partial thromboplastin time. American Journal of Clinical Pathology 1993, 100:94-98.
7. Cioni G., Cristani A., Tincani E., Ventura P., Zagni G., Ventura E. Time sequence of coagulation data in patients with decompensated liver cirrhosis and suspected disseminated intravascular coagulation. La Ricerca in clinica e in laboratorio 1991, 21:105-109.
8. Clauss A. Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens [Rapid physiological coagulation method in determination of fibrinogen]. Acta Haematologica 1957, 17:237-246.
9. Colucci M., Binetti B.M., Branca M.G., Clerici C., Morelli A., Semeraro N., Gresele P. Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis. Hepatology 2003, 38:230-237.
10. Griffin A., Callan M.B., Shofer F.S., Giger U. Evaluation of a canine D-dimer point-of-care test kit for use in samples obtained from dogs with disseminated intravascular coagulation, thromboembolic disease, and hemorrhage. American Journal of Veterinary Research 2003, 64:1562-1569.
11. Hollestelle M.J., Thinnes T., Crain K., Stiko A., Kruijt J.K., van Berkel T.J., Loskutoff D.J., van Mourik J.A. Tissue distribution of factor VIII gene expression in vivo - a closer look. Thrombosis and Haemostasis 2001, 86:855-861.
12. Jørgensen B., Fischer E., Ingeberg S., Hollaender N., Ring-Larsen H., Henriksen J.H. Decreased blood platelet volume and count in patients with liver disease. Scandinavian Journal of Gastroenterology 1984, 19:492-496.
13. Kemkes-Matthes B., Bleyl H., Matthes K.J. Coagulation activation in liver diseases. Thrombosis Research 1991, 64:253-261.
14. Kerr R. New insights into haemostasis in liver failure. Blood Coagulation and Fibrinolysis 2003, 14:S43-S45.
15. Kim H.K., Lee D.S., Kang S.H., Kim J.Q., Park S., Cho H.I. Utility of the fibrinogen/C-reactive protein ratio for the diagnosis of disseminated intravascular coagulation. Acta Haematologica 2007, 117:34-39.
16. Ko S., Tanaka I., Kanehiro H., Kanokogi H., Ori J., Shima M., Yoshioka A., Giles A., Nakajima Y. Preclinical experiment of auxiliary partial orthotopic liver transplantation as a curative treatment for hemophilia. Liver Transplantation 2005, 11:579-584.
17. Kummeling A., Teske E., Rothuizen J., Van Sluijs F.J. Coagulation profiles in dogs with congenital portosystematic shunts before and after surgical attenuation. Journal of Veterinary Internal Medicine 2006, 20:1319-1326.
18. Lara-García A., Couto C.G., Iazbik M.C., Brooks M.B. Postoperative bleeding in retired racing greyhounds. Journal of Veterinary Internal Medicine 2008, 22:525-533.
19. Lettow E. Die blinde Leberpunktion nach Menghini beim Hund. Berliner Munchener Tierärztliche Wochenschrift 1963, 76:273-277.
20. Lisciandro S.C., Hohenhaus A., Brooks M. Coagulation abnormalities in 22 cats with naturally occurring liver disease. Journal of Veterinary Internal Medicine 1998, 12:71-75.
21. Lisman T., Leebeek F.W. Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment. Digestive Surgery 2007, 24:250-258.
22. Luzatto G., de Franchis G., Fabris F., Gerunda G.E., Girolami A. Increased proportion of giant platelets and platelet distribution width are better indicators of altered platelet homeostasis than mean platelet volume in liver cirrhosis. Folia Haematologica 1988, 115:719-726.
23. Mammen E.F. Coagulation abnormalities in liver disease. Hematology/Oncology Clinics of North America 1992, 6:1247-1257.
24. Mammen E.F. Coagulopathies of liver disease. Clinical Laboratory Medicine 1994, 14:769-780.
25. Mischke R. Influence of factor VIII: C and factor IX activity in plasmas of haemophilic dogs on the activated partial thromboplastin time measured with two commercial reagents. Haemophilia 2000, 6:135-139.
26. Mischke R. Optimization of coagulometric tests that incorporate human plasma for determination of coagulation factor activities in canine plasma. American Journal of Veterinary Research 2001, 62:625-629.
27. Mischke R., Nolte I. Laboratory diagnosis and differential diagnosis of disseminated intravascular coagulation in the dog. Berliner und Münchener Tierärztliche Wochenschrift 1992, 105:401-410.
28. Mischke R., Nolte I. Hemostasis: introduction, overview, laboratory techniques. Schalm's Veterinary Hematology 2000, 519-525. Lippincott Williams and Wilkins, Philadelphia, PA. B.F. Feldman, J.G. Zinkl, N.C. Jain (Eds.).
29. Mischke R., Pöhle D., Schoon H.A., Fehr M., Nolte I. Alterations of hemostasis in liver cirrhosis of the dog. Deutsch Tierärztliche Wochenschrift 1998, 105:43-47.
30. Mischke R., Diedrich M., Nolte I. Sensitivity of different prothrombin time assays to factor VII deficiency in canine plasma. Veterinary Journal 2003, 166:79-85.
31. Moritz A., Walcheck B.K., Weiss D.J. Evaluation of flow cytometric and automated methods for detection of activated platelets in dogs with inflammatory disease. American Journal of Veterinary Research 2005, 66:325-329.
32. Niles J.D., Williams J.M., Cripps P.J. Hemostatic profiles in 39 dogs with congenital portosystemic shunts. Veterinary Surgery 2001, 30:97-104.
33. Panasiuk A., Prokopowicz D., Zak J., Matowicka-Karna J., Osada J., Wysocka J. Activation of blood platelets in chronic hepatitis and liver cirrhosis P-selectin expression on blood platelets and secretory activity of beta-thromboglobulin and platelet factor-4. Hepato-Gastroenterology 2001, 48:818-822.
34. Paramo J.A., Rifon J., Fernandez J., Cuesta B., Rocha E. Thrombin activation and increased fibrinolysis in patients with chronic liver disease. Blood Coagulation and Fibrinolysis 1991, 2:227-230.
35. Pleşca L.A., Bodizs G., Cucuianu M., Colhon D. Hemostatic balance during the acute inflammatory reaction; with special reference to antithrombin III. Romanian Journal of Physiology 1995, 32:71-76.
36. Prater M.R. Acquired coagulopathy II: liver disease. Schalm's Veterinary Hematology 2000, 560-564. Lippincott Williams and Wilkins, Philadelphia, PA. B.F. Feldman, J.G. Zinkl, N.C. Jain (Eds.).
37. Pulitanò C., Aldrighetti L., Arru M., Finazzi R., Catena M., Guzzetti E., Soldini L., Comotti L., Ferla G. Preoperative methylprednisolone administration maintains coagulation homeostasis in patients undergoing liver resection: importance of inflammatory cytokine modulation. Shock 2007, 28:401-405.
38. Stockhaus C., van den Ingh T., Rothuizen J., Teske E. A multistep approach in the cytologic evaluation of liver biopsy samples of dogs with hepatic diseases. Veterinary Pathology 2004, 41:461-470.
39. Stokol T., Brooks M.B., Erb H.N., Mauldin G.E. D-dimer concentrations in healthy dogs and dogs with disseminated intravascular coagulation. American Journal of Veterinary Research 2000, 61:393-398.
40. Toulza O., Center S.A., Brooks M.B., Erb H.N., Warner K.L., Deal W. Evaluation of plasma protein C activity for detection of hepatobiliary disease and portosystemic shunting in dogs. Journal of the American Veterinary Medical Association 2006, 229:1761-1771.
41. Van den Ingh, T.S.G.A.M., Van Winkle, T., Cullen, J.M., Charles J.A., Desmet, V.J., 2006. Morphological classification of parenchymal disorders of the canine and feline liver. In: WSAVA Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Disease, first ed. (WSAVA Liver Standardization Group. ed.). Elsevier Limited, Oxford, pp. 85-101.
42. Van Thiel D.H., George M., Fareed J. Low levels of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with chronic liver disease. Thrombosis and Haemostasis 2001, 85:667-670.
43. Welles E.G., Boudreaux M.K., Tyler J.W. Platelet, antithrombin, and fibrinolytic activities in taurine-deficient and taurine-replete cats. American Journal of Veterinary Research 1993, 54:1235-1243.
44. Wigton D.H., Kociba G.J., Hoover E.A. Infectious canine hepatitis: animal model for viral induced disseminated intravascular coagulation. Blood 1976, 47:287-296.
45. Witters P., Freson K., Verslype C., Peerlinck K., Hoylaerts M., Nevens F., van Geet C., Cassiman D. Alimentary Pharmacology & Therapeutics 2008, 27:1017-1029.
46. Yamazaki M., Aoshima K., Mizutani T., Ontachi Y., Saito M., Morishita E., Asakura H., Matsuda T., Triplett D.A. Prednisolone inhibits endotoxin-induced disseminated intravascular coagulation and improves mortality in rats: importance of inflammatory cytokine suppression. Blood Coagulation and Fibrinolysis 1999, 10:321-330.
47. Yilmaz Z., Eralp O., Ilcol Y.O. Evaluation of platelet count and its association with plateletcrit, mean platelet volume, and platelet size distribution width in a canine model of endotoxemia. Veterinary Clinical Pathology 2008, 37:159-163.
48. Zelmanovic D., Hetherington E.J. Automated analysis of feline platelets in whole blood, including platelet count, mean platelet volume, and activation state. Veterinary Clinical Pathology 1998, 27:2-9.